MedPath

The Impact of a Societal Lockdown on Those With Spinal Cord and Brain Injuries

Completed
Conditions
Stroke
Spinal Cord Injuries
Brain Injuries
Registration Number
NCT04426071
Lead Sponsor
Lawson Health Research Institute
Brief Summary

Document and evaluate the impact of societal restrictions due to the pandemic on SCI- and ABI-related disability and functional impairments, and the resultant effects on psychological wellbeing, physical wellbeing and quality of life for those with SCI/ABI.

Detailed Description

The investigators will conduct a longitudinal survey to examine the impact of COVID19 on those with SCI and ABI. An a priori sample size of 117 individuals based on an alpha level of .05 and level of acceptable error at 3% was calculated. Anticipating for loss to follow up rate of up to 20%, a total of 142 participants will be recruited. Patients will be recruited among those who attend virtual medical appointments at Parkwood Institute for ABI and SCI. We will also liaise with SCI-Ontario and the Ontario Brain Injury Association to assist in the recruitment of additional participants. Those who consent will complete an online survey on enrollment into the study, and subsequently at 3 and 6 months. Demographic data of the individuals participating in the study will be recorded. Participants' access to health care services will be evaluated using the following subdomains: medical care, complementary care, medications/equipment, satisfaction/acceptability, affordability, ability to engage, and indirect support.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
142
Inclusion Criteria
  • stroke, spinal cord injury (traumatic and non-traumatic) or acquired brain injury (of all severities, including concussion)
  • live in the community
  • have the cognitive capacity to understand and complete the measures
Exclusion Criteria
  • does not have the cognitive capacity to understand and complete the measures
  • does not speak English

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in Fear of COVID-19baseline, 3 months, 6 months

Fear of COVID-19 Questionnaire

Secondary Outcome Measures
NameTimeMethod
Change in positive affect and well-beingbaseline, 3 months, 6 months

NeuroQol SF v1.0 - Pos. Affect \& Well-Being

Change in emotional and behavioural dyscontrolbaseline, 3 months, 6 months

NeuroQol SF v1.0 - Emotional \& Beh. Dyscontrol

Change in satisfaction with social roles and activitiesbaseline, 3 months, 6 months

NeuroQol SF v1.0 - Satisfaction w SRA

Change in sleep disturbancebaseline, 3 months, 6 months

NeuroQol SF v1.0 - Sleep Disturbance

Change in ability to participate in social roles and activitiesbaseline, 3 months, 6 months

NeuroQol SF v1.0 - Ability to Part. in SRA

Change in depressive symptomsbaseline, 3 months, 6 months

NeuroQol SF v1.0 - Depression

Change in fatiguebaseline, 3 months, 6 months

NeuroQol SF v1.0 - Fatigue

Change in stigmabaseline, 3 months, 6 months

NeuroQol SF v1.0 - Stigma

Change in cognitive functionbaseline, 3 months, 6 months

NeuroQol SF v1.0 - Cognitive Function

Change in social distancing strategies usedbaseline, 3 months, 6 months

23 questions about strategies to social distance

Change in anxietybaseline, 3 months, 6 months

NeuroQol SF v1.0 - Anxiety

Change in thoughts and feelings about social distancingbaseline, 3 months, 6 months

22 questions about social distancing

Trial Locations

Locations (1)

Lawson Health Research Institute

🇨🇦

London, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath